{ }
001122334455554433221100
001122334455554433221100

global bisoprolol fumarate market poised for significant growth through 2032

The Global Bisoprolol Fumarate market is projected to grow from USD 1.3 billion in 2023 to USD 2.0 billion by 2032, with a CAGR of 7%. This medication, primarily used for hypertension and heart-related conditions, is expected to see increased demand driven by regulatory changes and market dynamics across various regions, particularly in Europe and Asia-Pacific. Key players include Merck, Pfizer, and Novartis, with a focus on understanding market trends and competitive strategies.

Markets Aim for Fifth Consecutive Day of Gains with Key Stocks in Focus

Markets are poised to potentially extend their rally for a fifth consecutive day, with particular attention on Torrent Pharma and L&T. Investors are encouraged to stay updated with relevant content and transaction notifications.

Torrent Pharmaceuticals Acquires Three Anti-Diabetes Brands from Boehringer Ingelheim

Torrent Pharmaceuticals is set to acquire three anti-diabetes brands from Boehringer Ingelheim GmbH: Cospiaq (empagliflozin), Cospiaq Met (empagliflozin + metformin), and Xilingio (empagliflozin + linagliptin). The deal, which follows a co-marketing agreement initiated in 2022, is expected to be finalized by March 2025.

Torrent Pharma Acquires Three Anti-Diabetes Brands from Boehringer Ingelheim

Torrent Pharma is enhancing its anti-diabetes portfolio by acquiring three brands from Boehringer Ingelheim, expected to finalize in March 2025. The brands—Cospiaq, Cospiaq Met, and Xilingio—contain Empagliflozin, a key treatment for type 2 diabetes, in a market projected to grow at a 25% CAGR. This move aims to improve patient access to diabetes care in India, which is anticipated to have 12.5 crore diabetes patients by 2045.

trading insights for siemens torrent pharma and other key stocks

On Wednesday, traders are advised to consider strategies for stocks including Siemens, Torrent Pharma, Data Patterns, CAMS, PB Fintech, and LTIMindtree. Additionally, there is an option to receive push notifications for relevant content and transaction updates.

torrent pharma shares gain after usfda inspection concludes with voluntary action

Torrent Pharma shares experienced an uptick following the USFDA's conclusion of an inspection at its Pithampur manufacturing facility, which was classified as 'Voluntary Action.' The inspection, conducted in the September quarter, resulted in a Form 483 with one observation.

Global Market for Premature Ejaculation Treatment Expected to Reach 7.59 Billion by 2032

The global market for premature ejaculation treatment is projected to grow from $3.75 billion in 2024 to $7.59 billion by 2032, driven by increased awareness, innovative treatment options, and the impact of the COVID-19 pandemic on healthcare access. Key players like Pfizer and Eli Lilly are focusing on R&D and collaboration to enhance their market presence. Stigma and cultural barriers remain significant challenges to market growth, despite a rising acceptance of sexual health issues.

Madhusudan Kela's wife acquires stake in Godavari Biorefineries amid market activity

Madhuri Madhusudan Kela acquired a 1.19% stake in Godavari Biorefineries Ltd by purchasing 500,000 shares at ₹335.66 each, while the company's shares closed at ₹342.85 after listing. Capri Global Capital Limited sold 374,382 shares, representing a 0.89% stake, at ₹327.98 each. Additionally, Torrent Investments offloaded 4,972,020 shares of Torrent Pharmaceuticals Ltd, leading to a 2.30% drop in the stock price, which closed at ₹3137.15.

torrent pharma shares fall 4 percent amid major stake sale by promoter

Torrent Pharma's shares fell by 4% on October 30, trading at Rs 3,113.25, following a block deal worth Rs 3,238.90 crore, where promoter Torrent Investments is likely the seller. Approximately 1.04 crore shares, representing a 3.1% stake, changed hands at an average price of Rs 3,108, significantly increasing trading volumes beyond the monthly average.

Indian equity market gains as banks drive momentum ahead of earnings reports

Indian equity markets extended gains, rising half a percent but remained below the crucial 100-day EMA of 24,475. The rally was primarily driven by banks, with experts noting that a decisive close above 24,500 is essential for further upward movement. Key stocks to watch include Marico and Torrent Pharma, while L&T and Dabur are set to report Q2 earnings today.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.